Fredun Pharmaceuticals Ltd has acquired drugmaker USV’s pet-wellness brand Furlicks, for an undisclosed sum.
The brand’s differentiated products, including oral-strip solutions for animals, marks FPL’s entry into the pet-wellness market. The acquisition was from USV and its subsidiary Wellbeing Nutrition.
“With pet parenting evolving from a predominantly need-based approach towards a more proactive focus on preventive health, the acquisition comes at a time when pet parents are becoming more aware and increasingly willing to invest in nutrition and specialised products for their pets,” a note on the development said.
Furlicks portfolio spans pet-wellness categories including skin and coat, gut health, joint care, calming, oral care and multivitamins – providing a foundation for category expansion and product innovation, the company said.
Fredun Medhora, FPL Managing Direct and Chief Finance Officer, said, “Our focus is to scale Furlicks while preserving what makes the brand special: its innovation, simplicity and deep understanding of pet parents.”
The immediate focus for FPL is on scaling the existing business by introducing 12 new SKUs in the first phase, with 32 new SKUs aligned for launch in the second phase, the company said.
Fredun Pharmaceuticals Limited (FPL) has been in healthcare for four decades, the company said, with a presence in pharmaceuticals, healthcare, consumer-facing wellness and specialised healthcare categories.